Microbot Medical Inc. — Director's Dealing 2017

Oct 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-10-15

Reporting Person: Himelfarb Yehezkel (Director, COO and General Manager)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-15	Stock Option (Right to Buy)	$1.29	A	1087627	Acquired	2027-10-15	Common Stock, par value $0.01 per share (1087627)	Direct

Footnotes

F1: The options vest as follows and in accordance with the terms of the Issuer's Equity Incentive Plan: (a) on the six month anniversary of the date of grant, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.